Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study

Archives of Internal Medicine

Volumn 156, Issue 3, 1996, Pages 286-289

  Ravid, Mordchai ^a   Lang, Ruth ^a   Rachmani, Rita ^a   Lishner, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK; TREATMENT OUTCOME;

EID: 0030056947     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.3.286     Document Type: Article

References (12)

1. Ruward D, Hoogluveen RT, Verkbeij H, Kromhout D, Casparie AF, Van derveen EA. Forecasting the number of diabetic patients in the Netherlands in 2005. Am J Pub Health. 1993;83.989-995
2. Kasiske BL, Kalil RSW, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes a meta-regression analysts. Ann Intern Med. 1993;118:129-138.
3. Lewis EJ, Hunsicker LG, Bain RP, Ronde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993; 329:1456-1462
4. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ. 1982;285 685-688.
5. Kamper AL, Strangaard S, Leyssac P. Effect of enalapril on the progression of chronic renal failure a randomized controlled trial. Am J Hypertens. 1992;5: 423-430.
6. Bjorck S, Mulec H, Johnsen SA, Worden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy BMJ. 1992,304.339-343
7. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopnl in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991;303:81-87.
8. Rudberg S, Asperia A, Freyschuss U, Persson B Enalapril reduces albuminuria in young normotensive type I (insulin-dependent) diabetic patients irrespective of its hypertensive effect Diabetologia. 1990;33.470-476.
9. Marre M, Chatellier G, Leblane H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092-1095
10. Ravid M, Savin H, Jutrin I, Bental T, Kats B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on protemuria in type II diabetic patients. Ann Intern Med. 1993;118:577-581.
11. Ravid M, Savin H, Jutrin I, Bental T, Lang R, Lishner M. Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II. Kidney Int 1994,45(suppl 45):161-164.
12. Almdal T, Norpaard K, Feldt-Rasmussen B, Dekert T. The predictive value of microaibuminuria in IDDM. Diabetes Care 1994;17:120-125.